PeptidePedia The community reference

Contributions of PurityClaimPia

User contributions·40 logged edits·page 1 of 1

Contributions by PurityClaimPia, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 1,444 edits includes activity predating the current log.

  1. 18:00, 26 Jul 2026 (diff | hist) Thermo Fisher Scientific (China) 14,517 +1,312 add the transit window each regional warehouse serves
  2. 15:58, 22 Jul 2026 (diff | hist) Sharps disposal 20,876 ±0 British spelling per PP:MOS
  3. 01:05, 15 Jul 2026 (diff | hist) ChinaPeptides 14,981 +2 m expand the product-scope row in the infobox
  4. 03:27, 19 Jun 2026 (diff | hist) PeptideMeter 4,925 ±0 add the second-opinion point: two services, one lot, is a stronger record
  5. 08:06, 25 May 2026 (diff | hist) GL Biochem (Shanghai) 16,491 ±0 add the note that this wiki publishes no score and no league table
  6. 05:50, 21 May 2026 (diff | hist) Sangon Biotech 14,764 ±0 add the research-use-only statement to the lead rather than only the footer
  7. 02:16, 20 May 2026 (diff | hist) PolyPeptide Group (Hangzhou) 18,363 ±0 add the note that self-published material is usable only for what it states about itself
  8. 17:33, 7 Apr 2026 (diff | hist) GL Biochem (Shanghai) 16,491 ±0 m add the how-to-request-a-batch-record sentence to §Ordering and availability
  9. 10:58, 4 Mar 2026 (diff | hist) Purity claim inflation 5,660 ±0 expand §Reading against inflation
  10. 23:11, 10 Feb 2026 (diff | hist) Batch number 4,573 ±0 correct the description of the sampling procedure
  11. 10:20, 3 Feb 2026 (diff | hist) Third-party testing 7,489 ±0 expand §Sampling and representativeness
  12. 13:05, 26 Jan 2026 (diff | hist) Talk:Purity claim inflation 611 +255 /* Title implies bad faith */ reply
  13. 11:30, 22 Jan 2026 (diff | hist) Counterfeit peptide 5,488 ±0 add the chain-of-custody point to §Limitations
  14. 05:18, 21 Jan 2026 (diff | hist) GenScript Peptides 14,288 +271 state the city and province of the registered address
  15. 00:20, 10 Dec 2025 (diff | hist) Dual incretin agonist 5,851 ±0 alphabetise the see-also list
  16. 20:01, 8 Dec 2025 (diff | hist) Purity claim inflation 5,660 ±0 add the citation for the blind-sampling discussion
  17. 06:04, 31 Oct 2025 (diff | hist) PeptideMeter 4,925 ±0 m expand §What an aggregate figure is
  18. 19:21, 19 Oct 2025 (diff | hist) Sigma-Aldrich (Shanghai) Trading 14,884 +1,392 add the note that this wiki publishes no score and no league table
  19. 08:07, 2 Oct 2025 (diff | hist) Active pharmaceutical ingredient 4,569 +214 add the year the guidance was issued
  20. 13:44, 7 Sep 2025 (diff | hist) PolyPeptide Group (Hangzhou) 2,688 +38 m add the registered legal name exactly as it appears in the registry record
  21. 07:32, 7 Jul 2025 (diff | hist) Certificate of analysis 9,449 +586 rm the ranking language; this wiki publishes no ranking
  22. 19:14, 21 Jun 2025 (diff | hist) Bachem Holding (Suzhou) 11,853 +265 add the standing talk-page note link to the banner
  23. 19:17, 17 Jun 2025 (diff | hist) Blind sampling 7,309 ±0 m state the method the reporting service uses, since it is not the only one available
  24. 17:33, 5 May 2025 (diff | hist) GLP-1 receptor agonist 9,758 +504 state plainly that the research-use-only form is not approved for human use
  25. 02:29, 23 Apr 2025 (diff | hist) Cold chain 20,418 ±0 de-orphan
  26. 04:21, 17 Apr 2025 (diff | hist) GL Biochem (Shanghai) 13,777 +810 m clarify that no manufacturing or marketing authorisation is claimed or established
  27. 17:31, 8 Feb 2025 (diff | hist) Research use only 6,689 +27 clarify that personal importation and commercial importation are different questions
  28. 09:13, 31 Jan 2025 (diff | hist) Shanghai Wibson Biotechnology 2,202 ±0 m clarify that a registered business scope is a licensing fact, not a quality assurance
  29. 19:44, 29 Jan 2025 (diff | hist) Exenatide 3,419 ±0 add the receptor targets to the lead sentence
  30. 07:11, 18 Jan 2025 (diff | hist) Guangzhou JEEP Biotechnology 8,327 +522 m rm the price; supplier articles carry no price per PP:VN
  31. 00:08, 17 Jan 2025 (diff | hist) Shanghai Wibson Biotechnology 1,761 ±0 m consistent en dashes in ranges
  32. 19:05, 7 Jan 2025 (diff | hist) Body composition assessment 3,229 ±0 m convert the interval table to include both conventional and SI units
  33. 10:02, 6 Jan 2025 (diff | hist) Tianjin Finder Chemical 5,400 +159 m unpipe a link that did not need piping
  34. 16:04, 19 Dec 2024 (diff | hist) Peptide aggregation 3,115 +34 add the repeatability figure with the number of injections
  35. 16:43, 16 Dec 2024 (diff | hist) Janoshik Analytical 3,738 +100 clarify that a QR code on a certificate proves issuance, not content
  36. 15:20, 10 Dec 2024 (diff | hist) Purity claim inflation 2,918 +31 rm the inference from one report to a supplier
  37. 18:25, 30 Nov 2024 (diff | hist) Certificate of analysis 5,485 ±0 add the point that reports reaching this wiki are not a sample of anything
  38. 03:31, 27 Nov 2024 (diff | hist) VendorInvestigate 2,881 +31 m alphabetise the see-also list
  39. 09:41, 22 Oct 2024 (diff | hist) Certificate of analysis 4,248 +389 ce per PP:MOS
  40. 08:06, 12 Sep 2024 (diff | hist) Batch number 2,461 +468 expand §Consistency checks